WILDEHALL_BLOODSTOCK_LIMI - Accounts


Company Registration No. 08721748 (England and Wales)
WILDEHALL BLOODSTOCK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2019
PAGES FOR FILING WITH REGISTRAR
WILDEHALL BLOODSTOCK LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2
WILDEHALL BLOODSTOCK LIMITED
BALANCE SHEET
AS AT
31 MAY 2019
31 May 2019
- 1 -
2019
2018
Notes
£
£
£
£
Current assets
Debtors
2
1,612
1,612
Cash at bank and in hand
575
575
2,187
2,187
Creditors: amounts falling due within one year
3
(247,530)
(247,530)
Net current liabilities
(245,343)
(245,343)
Capital and reserves
Called up share capital
4
2
2
Profit and loss reserves
(245,345)
(245,345)
Total equity
(245,343)
(245,343)

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 May 2019 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The directors acknowledge their responsibilities for:

  •     ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

  •     preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the board of directors and authorised for issue on 14 February 2020 and are signed on its behalf by:
Mr P E Wildes
Director
Company Registration No. 08721748
WILDEHALL BLOODSTOCK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MAY 2019
- 2 -
1
Accounting policies
Company information

Wildehall Bloodstock Limited is a private company limited by shares incorporated in England and Wales. The registered office is Wildes House, Worksop Road, Clowne, Chesterfield, S43 4TD.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

2
Debtors
2019
2018
Amounts falling due within one year:
£
£
Other debtors
1,612
1,612
3
Creditors: amounts falling due within one year
2019
2018
£
£
Other creditors
247,530
247,530
4
Called up share capital
2019
2018
£
£
Ordinary share capital
Issued and not fully paid
2 Ordinary of £1 each
2
2
2019-05-312018-06-01true14 February 2020CCH SoftwareCCH Accounts Production 2019.301No description of principal activityMr P E WildesMr Anthony HallMr M A Wildes087217482018-06-012019-05-31087217482019-05-31087217482018-05-3108721748core:CurrentFinancialInstruments2019-05-3108721748core:CurrentFinancialInstruments2018-05-3108721748core:ShareCapital2019-05-3108721748core:ShareCapital2018-05-3108721748core:RetainedEarningsAccumulatedLosses2019-05-3108721748core:RetainedEarningsAccumulatedLosses2018-05-3108721748bus:Director12018-06-012019-05-3108721748core:WithinOneYear2019-05-3108721748core:WithinOneYear2018-05-3108721748bus:EntityNoLongerTradingButTradedInPast2018-06-012019-05-3108721748bus:PrivateLimitedCompanyLtd2018-06-012019-05-3108721748bus:SmallCompaniesRegimeForAccounts2018-06-012019-05-3108721748bus:FRS1022018-06-012019-05-3108721748bus:AuditExemptWithAccountantsReport2018-06-012019-05-3108721748bus:Director22018-06-012019-05-3108721748bus:CompanySecretary12018-06-012019-05-3108721748bus:FullAccounts2018-06-012019-05-31xbrli:purexbrli:sharesiso4217:GBP